We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAM icon
2251
Brookfield Asset Management
BAM
$75.6B
$635K ﹤0.01%
+22,150
New +$667K
CBIO
2252
Crescent Biopharma
CBIO
$546M
$633K ﹤0.01%
+2,089
New +$308K
DADA
2253
DELISTED
Dada Nexus
DADA
$631K ﹤0.01%
90,597
+77,966
+617% +$408K
COMP icon
2254
Compass
COMP
$8.67B
$628K ﹤0.01%
+269,700
New +$708K
FC icon
2255
Franklin Covey
FC
$239M
$627K ﹤0.01%
13,411
+2,362
+21% +$115K
WCLD
2256
WisdomTree Cloud Computing Fund
WCLD
$270M
$625K ﹤0.01%
+24,939
New +$640K
TFC icon
2257
PUT
Truist Financial
TFC
$63.9B
$624K ﹤0.01%
+14,500
New +$636K
FPXI icon
2258
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$261M
$620K ﹤0.01%
15,963
+400
+3% +$15K
RYTM icon
2259
Rhythm Pharmaceuticals
RYTM
$7.31B
$620K ﹤0.01%
+21,283
New +$547K
REPX icon
2260
Riley Exploration Permian
REPX
$728M
$619K ﹤0.01%
21,028
-21,425
-50% -$609K
OCEAW
2261
CALL
DELISTED
Ocean Biomediacal, Inc. Warrants
OCEAW
$618K ﹤0.01%
59,403
KLXE icon
2262
KLX Energy Services
KLXE
$43.1M
$617K ﹤0.01%
+35,639
New +$502K
ACLS icon
2263
Axcelis
ACLS
$3.44B
$617K ﹤0.01%
+7,769
New +$547K
PVBC
2264
DELISTED
Provident Bancorp
PVBC
$616K ﹤0.01%
+84,682
New +$859K
MCRI icon
2265
Monarch Casino & Resort
MCRI
$2.2B
$616K ﹤0.01%
8,009
+1,095
+16% +$82.8K
FDN icon
2266
CALL
First Trust Dow Jones Internet Index Fund ETF
FDN
$4.99B
$616K ﹤0.01%
+5,000
New +$635K
MZTI
2267
The Marzetti Company
MZTI
$3.05B
$615K ﹤0.01%
3,118
-3,869
-55% -$735K
PACB icon
2268
Pacific Biosciences
PACB
$435M
$614K ﹤0.01%
75,100
-14,500
-16% -$125K
RUMBW
2269
CALL
RUM Group Inc Warrant
RUMBW
$12.1M
$614K ﹤0.01%
103,233
-7,219
-7% -$15.8K
GAIN icon
2270
Gladstone Investment Corp
GAIN
$642M
$611K ﹤0.01%
47,316
+3,972
+9% +$52.4K
COHR icon
2271
Coherent
COHR
$43.4B
$610K ﹤0.01%
17,372
-23,899
-58% -$831K
IXJ icon
2272
iShares Global Healthcare ETF
IXJ
$4.16B
$608K ﹤0.01%
7,160
-1,817
-20% -$150K
FET icon
2273
Forum Energy Technologies
FET
$578M
$607K ﹤0.01%
+20,578
New +$563K
IRAAW
2274
CALL
DELISTED
Iris Acquisition Corp Warrant
IRAAW
$606K ﹤0.01%
60,737
-114,259
-65% -$5.5K
LDHAW
2275
CALL
DELISTED
LDH Growth Corp I Warrant
LDHAW
$604K ﹤0.01%
59,998

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.